MCKINNEY, Texas, Oct. 23, 2024 /PRNewswire/ -- Globe Life Inc. (NYSE: GL) reported today that for the quarter ended September 30, 2024, net income was $3.44 per diluted common share, compared with $2.68 per diluted common share for the year-ago quarter. Net operating income for the quarter was $3.49 per diluted common share, compared with $2.71 per diluted common share for the year-ago quarter.HIGHLIGHTS:Net income as an ROE(1) was 22.4% for the nine months ended September 30, 2024. Net operating income as ...

MCKINNEY, Texas, Oct. 8, 2024 /PRNewswire/ -- Globe Life Inc. (NYSE: GL) will release Third Quarter 2024 earnings after the market closes on Wednesday, October 23, 2024. At that time, a copy of the Company's Third Quarter 2024 earnings press release and any other financial and statistical information about the quarter will be available on the Company's website at https://investors.globelifeinsurance.com/ under Financial Reports and Other Financial Information. In conjunction with the Third Quarter 2024 Earn ...

Vancouver, British Columbia--(Newsfile Corp. - October 3, 2024) - Trilogy AI Corp. (CSE: TRAI) (OTCQB: TRAIF) (FSE: Y920) (formerly, Ambari Brands Inc.) (the "Company") is pleased to announce a non-brokered private placement offering of up to 3,333,333 units of the Company ("Units") at a price of C$0.09 per Unit (the "Offering Price"), for aggregate proceeds of up to C$300,000 (the "LIFE Offering"). Each Unit will be comprised of one common share of the Company (a "Common Share") and one-half Common Share p ...

Campaign Encourages Open Dialogue With Doctor About Unmanaged Symptoms to Find the Right Treatment Option THOUSAND OAKS, Calif., Oct. 1, 2024 /PRNewswire/ -- Amgen (NASDAQ: AMGN) has partnered with multi-talented actress, producer and entrepreneur La La Anthony to share her personal journey living with plaque psoriasis, and to inspire people to be open with their doctors about how the disease affects their daily lives. As one of the more than 6 million people in the United States living with plaque psoriasi ...

This National Book Month, Club® Crackers is taking your group out of the chat and into your favorite series with the ultimate weekend getaway book clubs can reserve exclusively on HomeToGo CHICAGO, Sept. 30, 2024 /PRNewswire/ -- Have you ever wanted to literally live inside your favorite book? Club® Crackers gets the hype, with the '#BookTok' love amounting more than 220 billion views on TikTok and book club event listings on the rise1. To celebrate the love of good reads and good snacks with your club, Clu ...

Core Viewpoint - Therma Bright Inc. is conducting a non-brokered LIFE financing and a concurrent private placement to raise up to CAD$6 million through the issuance of common shares, aimed at enhancing working capital and supporting strategic initiatives [2][3][8]. Financing Details - The LIFE financing will involve issuing up to 50,000,000 common shares at a price of CAD$0.06 per share, with a total expected amount of CAD$3,000,000 [3][6]. - The concurrent private placement will also issue up to 50,000,000 common shares at the same price, targeting an additional CAD$3,000,000 [6]. - The LIFE financing is expected to close on or about October 18, 2024, subject to regulatory approvals [5]. Regulatory Compliance - The LIFE financing is conducted under the listed issuer financing exemption, allowing shares to be issued without a hold period in Canada, except Quebec [4]. - The concurrent private placement will have a statutory hold period of four months and one day following issuance [6][7]. Use of Proceeds - The net proceeds from both financings will be utilized to enhance the company's working capital, including funding for sales, marketing, and general operations [8]. Insider Participation - It is anticipated that insiders of the company will participate in the financings, which may be considered related party transactions but will be exempt from certain formal requirements [9]. Strategic Initiatives - The funds raised will support the implementation of the company's strategic plan, including driving sales for Venowave and advancing the Digital Cough Analyzer's FDA approval process [10].

Core Viewpoint - Luca Mining Corp. has successfully closed a fully subscribed brokered private placement and a concurrent non-brokered private placement, raising a total of C$11,306,775 for various operational purposes [1][5]. Financing Details - The brokered private placement resulted in the issuance of 19,000,000 LIFE Units at C$0.45 each, generating gross proceeds of C$8,550,000 [1] - The concurrent non-brokered private placement involved 6,126,167 Non-LIFE Units at the same price, yielding gross proceeds of C$2,756,775 [1] - Each Unit consists of one common share and one-half of a common share purchase warrant, with warrants exercisable at C$0.60 until March 26, 2026 [2] Agent and Compensation - Stifel acted as the lead agent for the LIFE Offering, with a syndicate including Haywood Securities Inc., Ventum Financial Corp., BMO Capital Markets, and Canaccord Genuity Inc. [3] - The agents received a 6% cash commission on the gross proceeds and 1,140,000 compensation warrants, also exercisable at C$0.45 until March 26, 2026 [3] Use of Proceeds - The net proceeds from the financings will be allocated to the Campo Morado Improvement Program, exploration drilling at Campo Morado and Tahuehueto, and commissioning of the Tahuehueto mill [5] Insider Participation - Two officers of the company participated in the concurrent private placement, acquiring a total of 1,030,000 Non-LIFE Units, which is classified as a related party transaction [6] Securities Regulations - The securities issued are subject to a statutory hold period until January 27, 2025, except for the LIFE Units which are not subject to such a hold period [4]

MINNEAPOLIS , Sept. 26, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that one of its spatial biology brands, Lunaphore, is partnering with Discovery Life Sciences (Discovery) to add Lunaphore COMET™, a best-in-class spatial biology platform, to Discovery's global suite of biospecimen products and specialty lab services supporting customers with clinical research. The strategic partnership leverages Lunaphore's COMET technology, the only fully-automated, highthroughput, hyperple ...

● . . Neotech Metals Corp. Commences Metallurgical Testing at its Hecla-Kilmer Property and Announces LIFE Offering September 26, 2024 4:00 AM EDT | Source: Neotech Metals Corp. Vancouver, British Columbia--(Newsfile Corp. - September 26, 2024) - Neotech Metals Corp. (CSE: NTMC) (OTC Pink: NTMFF) (FSE: V690) ("Neotech" or "the Company") is pleased to announce that, in partnership with SGS Laboratories ("SGS"), metallurgical testing has commenced on our flagship Hecla-Kilmer ("H/K") property. The testing aim ...

Tile's full integration with the Life360 app and network is a category-changing next step toward Life360's vision of keeping its members safe and close to the people, pets, and things they care about. The new multifunction button on Tile extends Life360's SOS feature to Tile devices. In an emergency, pressing the Tile button three times triggers a Life360 SOS alert, which sends a notification and the user's location information to their Life360 Circle and designated emergency contacts, letting them know som ...